Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2019. Start Trial.
Date Value
October 09, 2026 3.094
October 08, 2026 3.058
October 07, 2026 3.236
October 06, 2026 3.224
October 05, 2026 3.236
October 02, 2026 3.117
October 01, 2026 3.165
September 30, 2026 3.236
September 29, 2026 3.319
September 28, 2026 3.331
September 25, 2026 3.307
September 24, 2026 3.194
September 23, 2026 3.224
September 22, 2026 3.271
September 21, 2026 3.117
September 18, 2026 3.058
September 17, 2026 3.141
September 16, 2026 3.188
September 15, 2026 3.011
September 14, 2026 3.117
September 11, 2026 2.999
September 10, 2026 3.034
September 09, 2026 3.046
September 08, 2026 3.188
September 04, 2026 3.040
Date Value
September 03, 2026 2.987
September 02, 2026 2.987
September 01, 2026 2.939
August 31, 2026 2.975
August 28, 2026 2.975
August 27, 2026 3.046
August 26, 2026 2.987
August 25, 2026 3.046
August 24, 2026 2.916
August 21, 2026 2.904
August 20, 2026 2.904
August 19, 2026 2.916
August 18, 2026 2.845
August 17, 2026 2.762
August 14, 2026 2.785
August 13, 2026 2.750
August 12, 2026 2.762
August 11, 2026 2.774
August 10, 2026 2.726
August 07, 2026 2.726
August 06, 2026 2.714
August 05, 2026 2.690
August 04, 2026 2.667
August 03, 2026 2.548
July 31, 2026 2.513

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Tilray Brands, Inc. 0.2972
cbdMD, Inc. 0.4875
CannaPharmaRx, Inc. --
Cosmos Health, Inc. 1.360
Lexaria Bioscience Corp. 1.123

Price to Book Value Related Metrics

PS Ratio 0.4428
PEG Ratio -0.0408
Price to Free Cash Flow 20.80
Price 2.575
Earnings Yield -10.96%
Market Cap 228.91M
PEGY Ratio -0.0408
Operating PE Ratio 11.03